Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05130788
Other study ID # 20-01959
Secondary ID K01MD014165
Status Recruiting
Phase N/A
First received
Last updated
Start date February 10, 2022
Est. completion date December 31, 2024

Study information

Verified date October 2023
Source NYU Langone Health
Contact Nan Jiang, PhD
Phone (646) 501-3553
Email Nan.Jiang@nyulangone.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study team will develop and assess the feasibility and acceptability of a WeChat-based peer-group mobile messaging smoking cessation intervention targeting Chinese immigrant smokers in New York City (NYC). For Aim 1, the study team will develop a message library for the WeChat Quit Coach smoking cessation program and conduct in-depth interviews with 20 Chinese immigrant smokers in person to assess content relevance. For Aim 2, a two-arm, open-labeled, pilot randomized controlled trial (RCT) will be conducted to test the feasibility and acceptability of the WeChat Quit Coach intervention among 60 Chinese immigrant smokers. Participants will be randomized to intervention (n=40) or control group (n=20). Participants in the intervention group will receive a 6-week WeChat Quit Coach intervention through WeChat private group. Participants in the control group will receive a leaflet with information about existing smoking cessation programs that focus on Chinese American smokers. All the 60 participants will be offered a 4-week supple of nicotine replacement therapy (NRT) patches and/or lozenges. Participants will complete a baseline in-person survey at enrollment, a 6-week follow-up phone survey immediately after the intervention, and a 6-month follow-up phone survey. Biochemical test (exhaled carbon monoxide test) will be conducted to confirm abstinence among those who report no smoking in past 7-day at 6-week and 6-month follow-up surveys. Post-test in-depth interviews will be conducted with at least 20 participants in person from the intervention group at 6-week follow-up to obtain more information about the usability and perceptions about the WeChat Quit Coach program. For Aim 3, the investigators will conduct an open-labeled, 3-arm pilot RCT to test the preliminary effectiveness of the WeChat Quit Coach intervention with 90 Chinese immigrant smokers. Participants will be randomized to one of the three groups, including a 6-week intervention group A (IA; n = 30), a 12-week intervention group B (IB; n = 30), and a control group (n = 30). Participants in the intervention groups will either receive a 6-week (IA) or 12-week (IB) WeChat Quit Coach intervention through WeChat private groups. Participants in the control group will receive a leaflet with information of existing smoking cessation programs targeting Chinese American smokers. All 90 participants will be offered a 4-week free supply of NRT patches and/or lozenges. Participants will complete a baseline phone survey at enrollment, 12-week and 6-month follow-up phone surveys. A remote biochemical validation (saliva cotinine test) will be conducted at 12-week and 6-month follow-up to confirm smoking abstinence among those who self-report no smoking in the past 7 days. Post-test in-depth phone interviews will be conducted with up to 30 intervention participants to obtain more information about their perceptions and experience with the WeChat Quit Coach program.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date December 31, 2024
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: Aim 2: - Age 18-80 years - Chinese immigrant - Have smoked at least 100 cigarettes in a lifetime - Smoke =3 days per week - Be somewhat interested in quitting smoking - Has a Smartphone - Current WeChat user who uses WeChat on =3 days per week - Live in NYC - Can read and speak Chinese - Be able to provide consent Aim 3: - Age 18 years or above - Chinese immigrant - Have smoked at least 100 cigarettes in a lifetime - Smoke =1 days per week - Current WeChat user who uses WeChat on =3 days per week - Can read and speak Chinese Exclusion Criteria: Aim 2: - Current participation in other smoking cessation treatment program(s) - Be pregnant or breastfeeding Aim 3: - Current participation in other smoking cessation treatment program(s) - Be pregnant or breastfeeding - Having a household member who has enrolled in this study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
WeChat Quit Coach
WeChat Quit Coach intervention will be delivered via WeChat private groups for 6-12 weeks (<30 seconds per day). During the intervention period, participants will receive a text message at a fixed point of time every day (e.g., 8:00 am). The messages are designed to build motivations and skillset to quit smoking. Participants will also receive a daily group discussion question (e.g., "If you are to give one piece of advice to someone who has not made the decision to quit smoking, what would you say to his/her?"), and be encouraged to respond to the question. Participants can comment on group members' responses and ask questions related to smoking and quitting either in group (so everyone in the group can see the message) or directly to the coach (so only the coach can see the message). The coach will respond to the questions within 24 hours. The PI and the RA will moderate group discussions.
Leaflet
Participants in the control group will receive a leaflet with information about existing smoking cessation programs targeting Chinese American smokers.
Drug:
Optional Nicotine Replacement Therapy (NRT) Patches or Lozenges
Participants in both groups will be offered a 4-week supply of NRT patches and lozenges but not forced to use the medications. The medications are free to participants. If participants want to try or use the medications, the study team will mail the patches and lozenges (with a Chinese version of the instruction) or deliver in person.

Locations

Country Name City State
United States NYU Langone Health New York New York

Sponsors (4)

Lead Sponsor Collaborator
NYU Langone Health Asian Americans for Equality, Chinese American Planning Council, National Institute on Minority Health and Health Disparities (NIMHD)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Participants Who Respond to Daily Text Questions Measure of engagement. Measured among Aim 2 participants only. Up to Week 6 Follow-Up
Primary Number of Participants Who Ask Self-Composed Questions Measure of engagement. Measured among Aim 2 participants only. Up to Week 6 Follow-Up
Primary WeChat Program Participant Satisfaction Score A 5-point Likert scale will be used to report satisfaction. The total range in score is 1-5; the higher the score, the higher the satisfaction. Measured among Aim 2 participants only. Up to Week 6 Follow-Up
Primary Self-Reported 7-Day Point Prevalence Abstinence Rate at Month 6 Participants are asked whether they smoked cigarettes in the past 7 days. Measured among Aim 3 participants only. Month 6 Follow-Up
Secondary Number of Quit Attempts at Week 6 Measured among Aim 2 participants only. Week 6 Follow-Up
Secondary Number of Quit Attempts at Week 12 Measured among Aim 3 participants only. Week 12 Follow-Up
Secondary Number of Quit Attempts at Month 6 Month 6 Follow-Up
Secondary Average Daily Cigarette Consumption at Week 6 Measured among Aim 2 participants only. Week 6 Follow-Up
Secondary Average Daily Cigarette Consumption at Week 12 Measured among Aim 3 participants only. Week 12 Follow-Up
Secondary Average Daily Cigarette Consumption at Month 6 Month 6 Follow-Up
Secondary Self-Reported 7-Day Point Prevalence Abstinence Rate at Week 6 Participants are asked whether they smoked cigarettes in the past 7 days. Measured among Aim 2 participants only. Week 6 Follow-Up
Secondary Self-Reported 7-Day Point Prevalence Abstinence Rate at Week 12 Participants are asked whether they smoked cigarettes in the past 7 days. Measured among Aim 3 participants only. Week 12 Follow-Up
Secondary Self-Reported 7-Day Point Prevalence Abstinence Rate at Month 6 - Aim 2 Participants are asked whether they smoked cigarettes in the past 7 days. Measured Among Aim 2 participants only. Month 6 Follow-Up
Secondary Biochemically-Confirmed 7-Day Point Prevalence Abstinence Rate at Week 6 Participants are asked whether they smoked cigarettes in the past 7 days. Biochemical test (exhaled carbon monoxide test) will be conducted to confirm abstinence among those who report no smoking in past 7 days. Measured among Aim 2 participants only. Week 6 Follow-Up
Secondary Biochemically-Confirmed 7-Day Point Prevalence Abstinence Rate at Week 12 Participants are asked whether they smoked cigarettes in the past 7 days. Biochemical test (exhaled carbon monoxide test) will be conducted to confirm abstinence among those who report no smoking in past 7 days. Measured among Aim 3 participants only. Week 12 Follow-Up
Secondary Biochemically-Confirmed 7-Day Point Prevalence Abstinence Rate at Month 6 Participants are asked whether they smoked cigarettes in the past 7 days. Biochemical test (exhaled carbon monoxide test) will be conducted to confirm abstinence among those who report no smoking in past 7 days. Month 6 Follow-Up
Secondary Average Score or Knowledge About Harms of Smoking at Week 6 Participants are asked 5 questions on knowledge of the harms of smoking. The total range in the knowledge score is 0-5; the higher the score, the higher the knowledge level. Measured among Aim 2 participants only. Week 6 Follow-Up
Secondary Average Score or Knowledge About Harms of Smoking at Week 12 Participants are asked 5 questions on knowledge of the harms of smoking. The total range in the knowledge score is 0-5; the higher the score, the higher the knowledge level. Measured among Aim 3 participants only. Week 12 Follow-Up
Secondary Self-Efficacy for Quitting Smoking Score at Week 6 12-item questionnaire asking participants to indicate to what extent that they are sure that they could refrain from smoking in certain situations. Each item is ranked on a scale from 1 (Not at all sure) to 5 (Absolutely sure). The total score ranges from 12-60; higher scores indicate greater self-efficacy in quitting smoking. Measured among Aim 2 participants only. Week 6 Follow-Up
Secondary Self-Efficacy for Quitting Smoking Score at Week 12 12-item questionnaire asking participants to indicate to what extent that they are sure that they could refrain from smoking in certain situations. Each item is ranked on a scale from 1 (Not at all sure) to 5 (Absolutely sure). The total score ranges from 12-60; higher scores indicate greater self-efficacy in quitting smoking. Measured among Aim 3 participants only. Week 12 Follow-Up
Secondary Self-Efficacy for Quitting Smoking Score at Month 6 12-item questionnaire asking participants to indicate to what extent that they are sure that they could refrain from smoking in certain situations. Each item is ranked on a scale from 1 (Not at all sure) to 5 (Absolutely sure). The total score ranges from 12-60; higher scores indicate greater self-efficacy in quitting smoking. Month 6 Follow-Up
Secondary Number of Participants With Progression on Stage of Change for Smoking Cessation at Week 6 The 5 stages of change are: precontemplation, contemplation, preparation, action, and maintenance. Progression defined as moving from an early stage to an advanced stage (e.g., from pre-contemplation to contemplation, or contemplation to preparation stage). Measured among Aim 2 participants only. Week 6 Follow-Up
Secondary Number of Participants With Progression on Stage of Change for Smoking Cessation at Week 12 The 5 stages of change are: precontemplation, contemplation, preparation, action, and maintenance. Progression defined as moving from an early stage to an advanced stage (e.g., from pre-contemplation to contemplation, or contemplation to preparation stage). Measured among Aim 3 participants only. Week 12 Follow-Up
Secondary Number of Participants With Progression on Stage of Change for Smoking Cessation at Month 6 The 5 stages of change are: precontemplation, contemplation, preparation, action, and maintenance. Progression defined as moving from an early stage to an advanced stage (e.g., from pre-contemplation to contemplation, or contemplation to preparation stage). Measured among Aim 3 participants only. Month 6 Follow-Up
Secondary Number of Participants who Report NRT Use During Intervention Period at Week 6 Measured among Aim 2 participants only. Week 6 Follow-Up
Secondary Number of Participants who Report NRT Use During Intervention Period at Week 12 Measured among Aim 3 participants only. Week 12 Follow-Up
Secondary Number of Participants who Report NRT Use During Intervention Period at Month 6 Month 6 Follow-Up
See also
  Status Clinical Trial Phase
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Completed NCT04617444 - The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function N/A
Completed NCT02796391 - Facilitating Smoking Cessation With Reduced Nicotine Cigarettes Phase 2
Completed NCT03397511 - Incorporating Financial Incentives to Increase Smoking Cessation Among Asian Americans Residing in New York City N/A
Not yet recruiting NCT05188287 - A Culturally Tailored Smartphone Application for African American Smokers N/A
Recruiting NCT05264428 - The Effect of Honey on Lessening the Withdrawal Symptoms N/A
Recruiting NCT05846841 - Personalized Tobacco Treatment in Primary Care (MOTIVATE) N/A
Completed NCT04133064 - Assessment of the Pivot Breath Sensor: Single-Arm Cohort Study N/A
Completed NCT03187730 - Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants Phase 4
Completed NCT03474783 - To Explore the Factors Affecting the Effectiveness of Smoking Cessation N/A
Completed NCT04635358 - Feasibility Study of Smoking Cessation for the Staff of a Hospital Center N/A
Terminated NCT03670264 - BE Smokefree: Behavioral Economics Incentives to Engage Adolescents in Smoking Cessation N/A
Not yet recruiting NCT06307496 - VIDeOS for Smoking Cessation N/A
Completed NCT02905656 - Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit N/A
Completed NCT02997657 - Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial N/A
Completed NCT03206619 - A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Completed NCT02239770 - Pharmacokinetics of Nicotine Film in Smokers N/A
Completed NCT02562521 - A Smoking Cessation Intervention for Yale Dining Employees Phase 4
Recruiting NCT02422914 - Benefits of Tobacco Free Cigarette N/A